Abstract
Two new, sensitive and selective spectrofluorimetric methods have been developed for the determination of gemifloxacin (GFX) in tablets and spiked plasma samples. Gemifloxacin, as a primary amine compound, reacts with 7-chloro-4-nitrobenzofurazon (NBD-Cl) (for method A) and fluorescamine (for method B) which are a highly sensitive fluorogenic reagents used in many investigations. For method A, the reaction product was measured spectrofluorimetrically at 516 nm with excitation at 451 nm. The reaction proceeded quantitatively at pH 8.5, 80 °C in 7 min. For method B, the method was based on the reaction between GFX and fluorescamine in borate buffer solution of pH 8.5 to give highly fluorescent derivatives that were measured at 481 nm using an excitation wavelength of 351 nm. The fluorescence intensity was directly proportional to the concentration over the range 40–200 ng mL−1 and 100–1,200 ng mL−1 for method A and B, respectively. Successful applications of the developed methods, for the drug determination in pharmaceutical preparations and spiked plasma samples, were performed.
Similar content being viewed by others
References
Hohl AF, Frei R, Punter V, Graevenitz A, Knapp C, Washington J, Johnson D, Jones RN (1998) International multicenter investigation of LB20304, a new fluoronaphthyridone. Clin Microbiol Infect 4:280–284
World Medical Association (1996) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
Krishna MV, Sankar DG (2008) Utility of δ and π acceptors for the spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations. E-J Chem 5(3):493–498
Krishna MV, Sankar DG (2008) Spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations through ion-pair complex formation. E-J Chem 5(3):515–520
Elbashir AA, Saad B, Ali ASM, Al-Azzam KMM, Aboul-Enein HY (2008) Validated stability indicating assay of gemifloxacin and lomefloxacin in tablet formulations by capillary electrophoresis. J Liq Chromatogr Related Technol 31:1465–1477
Doyle E, Fowles SE, McDonnell DF, White SA (2000) Rapid determination of gemifloxacin in human plasma by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 746:191–198
Lee W, Yong Hong C (2000) Direct liquid chromatographic enantiomer seperation for new fluoroquinolones including gemifloxacin. J Chromatogr A 879(2):113–118
Cho SI, Shim J, Kim MS, Kim YK (2004) On-line sample cleanup and chiral separation of gemifloxacin in a urinary solution using chiral crown ether as a chiral selector in microchip electrophoresis. J Chromatogr A 1055:241–245
Ghosh PB, Whitehouse M (1968) 7-Chloro-4-nitrobenzofurazan: a new fluorogenic reagent for amino acids and other amines. Biochem J 108:155–156
Undefriend S, Stein S, Bohlem P, Dairman W, Leimgruber W, Weigele M (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (Washington, DC) 178:871–872
Taha EA, Salama NN, Fattah L (2006) Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1, 3-diazole (NBD-Cl). Chem Pharm Bull 54(5):653–658
Darwish IA, Amer SM, Abdine HH, Al-Rayes LI (2009) Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole. J Fluoresc 19(3):463–471
Hassan EM, Belal F, Al-Deeb OA, Khalil NY (2001) Spectrofluorimetric determination of vigabatrin and gabapentin in dosage forms and spiked plasma samples through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole. J AOAC Int 84(4):1017–1024
El-Emam AA, Hansen SH, Moustafa MA, El-Ashry SM, El-Sherbiny DT (2004) Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection. J Pharm Biomed Anal 34(1):35–44
Onal A, Kepekci SE, Oztunc A (2005) Spectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tablets. J AOAC Int 88(2):490–495
Onal A, Sagirli O (2009) Spectrophotometric and spectrofluorimetric methods for the determination of pregabalin in bulk and pharmaceutical preparation. Spectrochim Acta A Mol Biomol Spectrosc 72(1):68–71, Epub 2008 Aug 28
El-Enany N (2007) Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine. J AOAC Int 90(2):376–383
Suliman FE, Al-Lawati ZH, Al-Kindy SM (2008) A spectrofluorimetric sequential injection method for the determination of penicillamine using fluorescamine in the presence of beta-cyclodextrins. J Fluoresc 18(6):1131–1138, Epub 2008 May 22
Adamou R, Coly A, Douabalé SE, Saleck ML, Gaye-Seye MD, Tine A (2005) J Fluoresc 15(5):679–688
Aydogmus Z (2009) Simple and sensitive spectrofluorimetric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine. J Fluoresc 19(4):673–679, Epub 2009 Jan 28
Belal F, Abdine H, Al-Majed A, Khalil NY (2002) Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine. J Pharm Biomed Anal 27:253–260
Segura Carretero A, Cruces-Blanco C, Fernández Peinado S, El Bergmi R, Fernández Gutiérrez A (1999) Fluorimetric determination of procaine in pharmaceutical preparations based on its reaction with fluorescamine. J Pharm Biomed Anal 21:969–974
Lakowicz JR (1999) Principles of fluorescence spectroscopy. Kluwer Academic/Plenum, New York
Weber G, Teale FWJ (1957) Fluorescence excitation spectrum of organic compounds in solution-Part 1: systems with quantum yield independent of the exciting wavelenght. Trans Faraday Soc 53:640–648
Eastman JW (1967) Quantitative spectrofluorimetry—the fluorescence quantum yield of quinine sulfate. Photochem Photobiol 6:55–72
Rote AR, Pingle SP (2009) Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma. J Chromatogr, B 877(29):3719–3723
Pesez M, Batros J (1974) Colorimetric and fluorimetric analysis of organic compounds and drugs. Marcel Dekker, New York, p 170
Imai K, Toyo’oka T, Miyano H (1984) Fluorigenic reagents for primary and secondary amines and thiols in high-performance liquid chromatography: a review. Analyst 109:1365–1373
Imai K, Uzu S, Toyoóka T (1989) Fluorogenic reagents having benzofurazan structure in liquid chromatography. J Pharm Biomed Anal 7:1395–1403
Job P (1928) Formation and stability of inorganic complexes in solution. Anal Chem 9:113–203
Allen A, Bygate E, Oliver S, Johnson M, Ward C, Cheon AJ, Choo YS, Kim IC (2000) Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers. Antimicrob Agents Chemother 44(6):1604–1608
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kepekci Tekkeli, S.E., Önal, A. Spectrofluorimetric Methods for the Determination of Gemifloxacin in Tablets and Spiked Plasma Samples. J Fluoresc 21, 1001–1007 (2011). https://doi.org/10.1007/s10895-010-0759-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10895-010-0759-1